The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and
pathologic diagnosis of DLB incorporating new information about the core clinical features and …

▪ Abstract The defining neuropathological characteristics of Alzheimer's disease are abundant
filamentous tau lesions and deposits of fibrillar amyloid β peptides. Prominent filamentous …

The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in …

Lewy bodies, a defining pathological characteristic of Parkinson's disease and dementia with
Lewy bodies (DLB) 1 , 2 , 3 , 4 , constitute the second most common nerve cell pathology, …

Ubiquitin-positive, tau- and α-synuclein–negative inclusions are hallmarks of frontotemporal
lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. …

Currently available evidence strongly supports the position that the initiating event in
Alzheimer's disease (AD) is related to abnormal processing of β-amyloid (Aβ) peptide, ultimately …

Background: A consensus conference on multiple system atrophy (MSA) in 1998 established
criteria for diagnosis that have been accepted widely. Since then, clinical, laboratory, …

In 2010, we put forward a hypothetical model of the major biomarkers of Alzheimer's disease
(AD). The model was received with interest because we described the temporal evolution of …

Objective Develop a cerebrospinal fluid biomarker signature for mild Alzheimer's disease (AD)
in Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects. Methods Amyloid‐β 1 to …

Background Transplantation of human embryonic dopamine neurons into the brains of patients
with Parkinson's disease has proved beneficial in open clinical trials. However, whether …